[ad_1]
[email protected]
Maria del Pilar Quezada was diagnosed with hepatitis C in 2012, five years later she became one of the first 1,544 beneficiaries to benefit from innovative treatment that the # 39; IMSS included in his basic scheme, now free of the disease. 19659002] He learned of his illness because he went to donate blood for a family member at the Banco de Sangre de la Raza; When she was studied, she was informed that she was a carrier of the virus, so she was referred to the Gastroenterology Department to begin treatment.
Her diagnosis was depressed, as were the side effects of the medications she took: she lost weight. hair, felt nauseous and had no favorable results for controlling or eliminating hepatitis.
In April 2017, the IMSS announced the inclusion of direct-acting antivirals in its basic array. María has been subjected to several studies and was a candidate for drugs. Last October, he began treatment and in January he was informed that the viral load due to hepatitis was negative, in April the diagnosis was confirmed.
Source link
